Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 28 March 2027
- Last conf. stmt
- 14 March 2026
Astrazeneca Quest Limited
- Incorporated
- 14 March 1994 (32 years)
- Previously known as
- Zeneca Quest Limited (until 31 July 2000)Zenco (No. 7) Limited (until 6 November 1998)
- Industry
- Other business support service activities n.e.c. (82990)
- Owned by
- Accounts type
- Full
- Region
- East of England
- Address
- 1 Francis Crick AvenueCambridge Biomedical CampusCambridgeCB2 0AA
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 1 May 2025
British
Born July 1987 (39)
Director · Appointed 27 February 2019
British
Born December 1977 (48)
Johnstone, Camilla Jane
Secretary · Appointed 26 April 2017
Officer history (14 former)
1 May 2025
1 May 2025
27 February 2019
27 February 2019
26 April 2017
26 April 2017
Appointed Johnstone, Camilla Jane as Secretary
31 July 2015
15 July 2015
16 November 2012
8 November 2012
7 September 2012
Resigned Morris, David as Director
13 December 2011
13 December 2011
20 November 2006
20 November 2006
11 January 2001
Appointed Morris, David as Director
11 January 2001
11 January 2001
Resigned Macdonald, Colin James Francis as Director
11 January 2001
Resigned Steele, Ian Robert as Director
18 November 1999
30 September 1999
16 December 1998
16 December 1998
16 December 1998
16 December 1998
Appointed Steele, Ian Robert as Director
16 December 1998
16 December 1998
16 December 1998
Appointed Macdonald, Colin James Francis as Director
14 March 1994
14 March 1994
14 March 1994
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 03674842
Group structure 19 shown
Ownership group derived from the Companies House PSC register
Astrazeneca Intermediate Holdings Limited Owns 75–100% of shares
Astrazeneca UK Limited Owns 75–100% of shares
Alderley Park Ventures Limited Has significant influence or control
Astrazeneca Death in Service Trustee Limited Owns 75–100% of shares
Astrazeneca Employee Share Trust Limited Owns 75–100% of shares
Astrazeneca Nominees Limited Owns 75–100% of shares
Astrazeneca Quest Limited This company Owns 75–100% of shares
Astrazeneca Share Trust Limited Owns 75–100% of shares
Astrazeneca Treasury Limited Owns 75–100% of shares
British Pharma Group Limited Holds 25–50% of voting rights
Evinova Limited Owns 75–100% of shares
Kudos Pharmaceuticals Limited Owns 75–100% of shares
Medimmune U.K. Limited Owns 75–100% of shares
Filings 136
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 13 April 2026 | Full accounts | 31 December 2025 | ||
| 16 March 2026 | Confirmation statement with no updates | 14 March 2026 | ||
| 2 May 2025 | Appointment of a director | |||
| 1 May 2025 | Termination of appointment of a director | |||
| 17 April 2025 | Full accounts | 31 December 2024 |
Some other companies at this address
Other companies in this industry
London
Moreton-In-Marsh
Salford
Eaton Socon
Chorley
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →